Mira Pharmaceuticals Inc
NASDAQ:MIRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mira Pharmaceuticals Inc
NASDAQ:MIRA
|
US |
|
Bright Brothers Ltd
BSE:526731
|
IN |
|
Goodyear Lastikleri TAS
IST:GOODY.E
|
TR |
|
T
|
Tong Ren Tang Technologies Co Ltd
SWB:TNG
|
CN |
|
Pixel Companyz Inc
TSE:2743
|
JP |
|
HDC Labs Co Ltd
KRX:039570
|
KR |
|
Anhui Jiuhuashan Tourism Development Co Ltd
SSE:603199
|
CN |
|
Emerge Commerce Ltd
XTSX:ECOM
|
CA |
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
CN |
|
M
|
Magadh Sugar & Energy Ltd
NSE:MAGADSUGAR
|
IN |
|
Getinge AB
STO:GETI B
|
SE |
|
R
|
Rastar Environmental Protection Materials Co Ltd
SZSE:300834
|
CN |
|
C
|
Chow Tai Seng Jewellery Co Ltd
SZSE:002867
|
CN |
|
K
|
KOALA Financial Group Ltd
HKEX:8226
|
HK |
Profitability Summary
Mira Pharmaceuticals Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
Margins
Earnings Waterfall
Mira Pharmaceuticals Inc
Margins Comparison
Mira Pharmaceuticals Inc Competitors
| Country | Company | Market Cap |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|
| US |
M
|
Mira Pharmaceuticals Inc
NASDAQ:MIRA
|
41.5m USD |
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD |
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.5B USD |
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF |
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.1B GBP |
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
288B USD |
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF |
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.3B USD |
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.5B USD |
Loading...
|
Loading...
|
Return on Capital
Return on Capital Comparison
Mira Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| US |
M
|
Mira Pharmaceuticals Inc
NASDAQ:MIRA
|
41.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
288B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
